Business Context and Reporting Period
Company: National Research Corporation (NRC Health)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007
Business Overview: NRC Health provides survey-based performance measurement, analysis, tracking, and governance education services to the healthcare industry in the U.S. and Canada. The company assists healthcare organizations in complying with regulatory standards and improving business practices.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Revenues | $12,204,981 | $9,476,383 |
| Operating Income | $2,729,571 | $1,900,149 |
| Net Income | $1,594,018 | $1,216,922 |
| Diluted EPS | $0.23 | $0.18 |
| Operating Cash Flow | $4,373,948 | $1,231,463 |
| Cash and Equivalents (End of Period) | $1,357,874 | $1,030,900 |
| Total Debt (Notes Payable) | $8,335,611 | Not explicitly stated for Q1 2006 |
| Working Capital | ($447,350) Deficiency | Not explicitly stated for Q1 2006 |
Note: Total Debt calculated as Current portion of note payable ($726,540) + Note payable net of current portion ($7,609,071).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 28.8% year-over-year, driven by expanded scope of work with existing clients, new client additions, and $2.1 million in revenue from the TGI Group acquisition.
- Expense Increases:
- Direct Expenses: Rose 32.9% to $5.4 million, increasing as a percentage of revenue to 44.6% (from 43.3%) due to business mix and TGI integration costs (printing, postage, conferences).
- Selling, General & Administrative (SG&A): Increased 13.1% to $3.4 million, primarily due to TGI-related salary and benefit expenses. However, SG&A as a percentage of revenue improved to 27.9% (from 31.7%).
- Depreciation & Amortization: Increased 33.4% to $627,000, largely due to amortization of intangibles from the TGI acquisition.
- Profitability: Operating margin expanded to 22.4% from 20.0%. Net income increased 31.0%.
- Liquidity: Operating cash flow surged to $4.4 million from $1.2 million. The company reduced its working capital deficiency from $1.5 million (Dec 31, 2006) to $447,000 (Mar 31, 2007) by paying down the revolving line of credit.
Guidance, Outlook, and Risks
- Expense Outlook: Management expects direct expenses to remain in the 43%–45% range of total revenues for the remainder of 2007. SG&A is expected to be higher than the historical 23%–25% model due to share-based compensation (SFAS 123R) but should decrease in the second half of the year.
- Capital Expenditures: Budgeted at approximately $1.5 million for 2007, funded by operations, focusing on hardware, software, and facility improvements.
- Debt Maturity: The $3.5 million revolving credit facility matures on July 31, 2007. Management expects to extend the term for at least one year. The term note matures in May 2013.
- Share Repurchases: The company has 695,483 shares remaining under its authorized repurchase program as of March 31, 2007.
- Risks: No material changes to risk factors were reported since the 2006 10-K. Key risks include reliance on the healthcare industry and the ability to maintain financial covenants.
Investor Verification Checklist
- Debt Covenants: Verify continued compliance with financial ratios required by the credit facility, especially given the working capital deficiency.
- Revolving Credit Extension: Confirm the status of the extension for the $3.5 million revolving credit facility maturing July 31, 2007.
- Acquisition Integration: Monitor the realization of synergies and revenue growth from the TGI Group acquisition against the $2.1 million contribution in Q1.
- Deferred Revenue: Review the $10.5 million in "Billings in excess of revenues earned" to ensure timely recognition as work is completed.
- Share-Based Compensation: Assess the impact of SFAS 123R on future earnings, as SG&A margins are currently elevated due to these non-cash expenses.